Aluminum hydroxide 80 mg / magnesium trisilicate 20 mg Chewable Tablet [Foamicon]
RxNorm 212045
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 212045 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: aluminum hydroxide 80 mg / magnesium trisilicate 20 mg Chewable Tablet [Foamicon].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Aluminum hydroxide 80 mg / magnesium trisilicate 20 mg Chewable Tablet [Foamicon]
(Atom ID: 12356462)
SY